Appointment of Joint Broker
Source: RNS
29 November 2022
Empresaria Group plc
("Empresaria" or the "Company")
Appointment of Joint Broker
AIM Rule 17 - historic disclosure
Empresaria, the global specialist staffing group, is pleased to announce the appointment of Cenkos Securities plc as the Company's joint broker with immediate effect.
The Company also announces the following disclosure in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies that had previously been omitted in error.
As announced at her appointment as a director of the Company on 13 December 2005, Penny Freer was a director of Peacock Blue Limited from 18 August 2005. Peacock Blue Limited subsequently entered into administration on 17 January 2007, creditors' voluntary liquidation on 13 August 2007 and was dissolved on 6 November 2010.
- Ends -
Enquiries:
|
Empresaria Group plc |
via Alma PR |
|
Singer Capital Markets (Nominated Adviser and Joint Broker) |
020 7496 3000 |
|
Cenkos Securities (Joint Broker) |
020 7397 3900 |
|
Alma PR (Financial PR) Hilary Buchanan |
020 3405 0205 |
Notes for editors:
§ Empresaria Group plc is a global specialist staffing group. We are driven by our purpose to positively impact the lives of people, while delivering exceptional talent to our clients globally. We offer temporary and contract recruitment, permanent recruitment and offshore services across six sectors: Professional, IT, Healthcare, Property, Construction & Engineering, Commercial and Offshore Services.
§ Empresaria is structured in four regions (UK & Europe, APAC, Americas and Offshore Services) and operates from locations across the world including the four largest staffing markets of the US, Japan, UK and Germany along with a strong presence elsewhere in Asia Pacific and Latin America.
§ Empresaria is listed on AIM under ticker EMR. For more information visit www.empresaria.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
